Pages
National Inclusion week 2025
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/national-inclusion-week-2025
Annual Member's Meeting (AMM) 2025
AMM (Annual Members Meeting) for DCHS November 2025
https://dchs.nhs.uk/about-us/council-governors/become-member/annual-members-meeting
Scam police calls reported in Derbyshire
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/scam-police-calls-reported-derbyshire
Carers Staff Network
https://dchs.nhs.uk/about-us/equality-diversity-inclusion/staff-networks/carers-staff-network
Virtual ward helps Derbyshire patients stay at home for Christmas and New Year
https://dchs.nhs.uk/news/virtual-ward-helps-derbyshire-patients-stay-home-christmas-and-new-year
Dr Chris Clayton appointed as Chief Executive Designate JUCD
The appointment of Dr Chris Clayton as Chief Executive Designate of the NHS Integrated Care Board for Derby and Derbyshire.
Files
Guidance for Wound Clinic Services for the use of tap water on chronic wounds (G308)
Guidance for Wound Clinic Services for the use of tap water on chronic wounds
L313 - Anticipatory Medicines and Syringe Drivers (Inpatients) Leaflet
L313 - Anticipatory Medicines and Syringe Drivers (Inpatients) Leaflet
DCHS Scheme Of Delegation
Scheme Of Delegation - April 2025
A2 - Catheter Clinical Appointment Letter (G324)
Catheter Clinical Appointment Letter
Disclosure Ref 2024131 - Cyber Security Attacks.pdf
FOI Disclosure relating to Cyber Security Attacks
Disclosure Ref 2024124 - Sub Contracting of Online Online Sexual Health Services.pdf
Disclosure Ref 2024124 - Sub Contracting of Online Online Sexual Health Services
Disclosure Ref 2024134 - Self Declaration July 2021.pdf
Disclosure Ref 2024134 - Self Declaration July 2021
INR Testing procedure within Derbyshire Community Health Services by Podiatry Surgery at Ilkeston and Buxton Hospitals (S128)
Only podiatric surgery with the relevant equipment, training and framework in place will be able to utilise this procedure. This clinical procedure will support clinical staff in practice to include arrangements with regards the procedure of the taking of the INR test, quality assurance /quality control, Control of Substances Hazardous to Health (COSHH) assessment, Infection control measures, and any relevant Health and Safety issues. In line with recommendations within the Medicines and Healthcare Products Regulatory Agency (MHRA) Device Bulletin “Management and use of In Vitro Diagnostic (IVD) Point of Care Test Devices DB 2010(02) February 2010
A1 - Observational Audit - protected meal times (G50)
Observational Audit - protected meal times
Integrated Performance Report - November 2024
Integrated Performance Report - November 2024